MAY 26·SEC EDGARLow
Firestone Karen purchased $51K of AMLX
Firestone Karen purchased 3,800 shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $13.51 on 2026-05-21.
StockHealthcare · Drug Manufacturers - Specialty & Generic
$AMLX
Amylyx Pharmaceuticals, Inc.
Price · $AMLXvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 2
- Neutral
- 0
- Bearish
- 0
Top stories · $AMLXMore →
MAY 25·finance.yahoo.com
Amylyx Stock: Why the Full Pipeline Story Matters
MarketBeat says Amylyx’s pipeline matters for investors, highlighting AMX0035 for Wolfram Syndrome in Phase 2 HELIOS. The article cites positive Week 24 and Week 48 results and plans to share Week 96 data later in 2026; it estimates a global market of 15,000–30,000 patients. It also notes AMX0114 for ALS, with Cohort 2 enrollment completed in March 2026 and early Cohort 1 biomarker data expected in June 2026, plus FDA Fast Track. MarketBeat’s consensus price target is $23.
MAR 17·Simply Wall St
How Investors May Respond To Amylyx Pharmaceuticals (AMLX) Narrowed 2025 Losses And Expanded Shelf Capacity
Amylyx Pharmaceuticals reported narrowed net losses for Q4 and full-year 2025, alongside new shelf registrations for various securities. These developments suggest increased financial flexibility for future growth, though potential shareholder dilution remains a concern. The company's investment narrative now focuses on advancing its pipeline while managing capital needs.